中国合理用药探索2024,Vol.21Issue(7) :99-103.DOI:10.3969/j.issn.2096-3327.2024.07.015

84例接骨七厘制剂不良反应分析与管理建议

Analysis and Management Suggestions of 84 Cases of Adverse Reactions of Jiegu Qili Preparation

龙慧玲 贺先琳
中国合理用药探索2024,Vol.21Issue(7) :99-103.DOI:10.3969/j.issn.2096-3327.2024.07.015

84例接骨七厘制剂不良反应分析与管理建议

Analysis and Management Suggestions of 84 Cases of Adverse Reactions of Jiegu Qili Preparation

龙慧玲 1贺先琳2
扫码查看

作者信息

  • 1. 湖南省药品审评与不良反应监测中心,长沙 410013
  • 2. 湖南省药品审核查验中心,长沙 410001
  • 折叠

摘要

目的:分析接骨七厘制剂的药品不良反应(ADR)发生特征,为其安全合理用药提供参考.方法:收集2010年1月1日~2022年12月6日期间国家药品不良反应监测系统中有关接骨七厘制剂的ADR报告,采用回顾性研究方法对患者性别、年龄、用药原因、严重ADR报告、ADR累及系统/器官及主要临床表现、合并用药进行统计分析.结果:共收集了84例ADR报告,其中男性患者略多于女性患者,患者年龄多分布在45~64岁(36.90%),主要用药原因为骨折(51.19%),有11例严重ADR报告,ADR累及系统/器官主要为胃肠系统疾病(61.15%),与活血止痛胶囊联用时出现的ADR较多.结论:在临床使用中应当加强接骨七厘制剂ADR监测,确保患者用药合理安全.

Abstract

Objective:To analyze the pattern of adverse drug reaction(ADR)of Jiegu Qili preparation,providing a reference for safe and rational drug use.Methods:The ADR reports of Jiegu Qili preparation from January 1,2010 to December 6,2022 in the National Adverse Drug Reaction Monitoring System were collected.The gender,age,medication reasons,serious ADR reports,ADR involving system/organ and main clinical manifestations,and concomitant medications were statistically analyzed by a retrospective study.Results:A total of 84 cases of ADR were collected.Male patients were slightly more than female patients,and the age of patients was mainly distributed in 45~64 years old(36.90%).The main reason for medication was fracture(51.19%).There were 11 cases of serious ADR reported,and the ADR involving system/organ were mainly gastrointestinal disorders(61.15%),with an increase in ADR when combined with Huoxue Zhitong capsules.Conclusion:The monitoring of ADR associated with Jiegu Qili preparation in clinical application should be strengthened to ensure the safe and rational drug use for patients.

关键词

接骨七厘制剂/药品不良反应/合理用药/不良反应监测/分析

Key words

Jiegu Qili preparation/adverse drug reaction/rational drug use/adverse drug reaction monitoring/analysis

引用本文复制引用

出版年

2024
中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
段落导航相关论文